Top

Tumor Biology

Published in:

01-09-2016 | Original Article

The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma

Published in: Tumor Biology | Issue 9/2016

Title: The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma
Publication date: 01-09-2016
Published in: Tumor Biology / Issue 9/2016
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI: https://doi.org/10.1007/s13277-015-4773-4

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 9/2016

Emerging targets for radioprotection and radiosensitization in radiotherapy

Erratum to: Spheroid-plug model as a tool to study tumor development, angiogenesis, and heterogeneity in vivo

Expression profiles of miR-29c, miR-200b and miR-375 in tumour and tumour-adjacent tissues of head and neck cancers

Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia

Primary cultures of human colon cancer as a model to study cancer stem cells

Potential biomarkers for anti-EGFR therapy in metastatic colorectal cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer